Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
crispr
4
×
editas medicine
biotech
boston blog main
boston top stories
gene editing
life sciences
national blog main
allergan
boston
clinical trials
cynthia collins
government
katrine bosley
san francisco blog main
abbvie
advaxis
aimmune therapeutics
alder biopharmaceuticals
alexander hardy
alzheimer's disease
andrew oxtoby
babies
bill gates
bio
boulder/denver blog main
boulder/denver top stories
breakup
bridge bio pharma
ceo
clinical hold
clinical study
combination
commissioner
congress
crispr-cas9
deals
delisting
democrats
departure
What
editas
4
×
crispr
editing
gene
biotech
ceo
experimental
katrine
medicine
abbvie
allergan
alliance
believe
big
bio
blessing
bosley
bosley's
bosley’s
bridge
bucks
built
cas
check
clinical
company’s
concerns
crime
cusp
debut
depart
departure
dispute
drop
drops
exit
exits
far
genetic
guiding
Language
unset
Current search:
editas
×
crispr
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
@techcrunch.com
8 years ago
Editas biotech stock drops by 26% over CRISPR patent dispute
